Literature DB >> 20818416

The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.

C Andradas1, M M Caffarel, E Pérez-Gómez, M Salazar, M Lorente, G Velasco, M Guzmán, C Sánchez.   

Abstract

GPR55 is an orphan G protein-coupled receptor that may be engaged by some lipid ligands such as lysophosphatidylinositol and cannabinoid-type compounds. Very little is known about its expression pattern and physio-pathological relevance, and its pharmacology and signaling are still rather controversial. Here we analyzed the expression and function of GPR55 in cancer cells. Our data show that GPR55 expression in human tumors from different origins correlates with their aggressiveness. Moreover, GPR55 promotes cancer cell proliferation, both in cell cultures and in xenografted mice, through the overactivation of the extracellular signal-regulated kinase cascade. These findings reveal the importance of GPR55 in human cancer, and suggest that it could constitute a new biomarker and therapeutic target in oncology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818416     DOI: 10.1038/onc.2010.402

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  79 in total

1.  Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

Authors:  Maria Elena Meza-Aviña; Mary A Lingerfelt; Linda M Console-Bram; Thomas F Gamage; Haleli Sharir; Kristen E Gettys; Dow P Hurst; Evangelia Kotsikorou; Derek M Shore; Marc G Caron; Narasinga Rao; Larry S Barak; Mary E Abood; Patricia H Reggio; Mitchell P Croatt
Journal:  Bioorg Med Chem Lett       Date:  2016-02-16       Impact factor: 2.823

2.  The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.

Authors:  Xiao-Lei Zhou; Xin Guo; Yu-Pin Song; Chong-Yue Zhu; Wei Zou
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

3.  Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.

Authors:  Evangelia Kotsikorou; Karla E Madrigal; Dow P Hurst; Haleli Sharir; Diane L Lynch; Susanne Heynen-Genel; Loribelle B Milan; Thomas D Y Chung; Herbert H Seltzman; Yushi Bai; Marc G Caron; Larry Barak; Mary E Abood; Patricia H Reggio
Journal:  Biochemistry       Date:  2011-06-01       Impact factor: 3.162

4.  Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Authors:  Artur Wnorowski; Justyna Such; Rajib K Paul; Robert P Wersto; Fred E Indig; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2017-05-08       Impact factor: 4.315

5.  Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.

Authors:  N A Balenga; E Martínez-Pinilla; J Kargl; R Schröder; M Peinhaupt; W Platzer; Z Bálint; M Zamarbide; I G Dopeso-Reyes; A Ricobaraza; J M Pérez-Ortiz; E Kostenis; M Waldhoer; A Heinemann; R Franco
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

6.  GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.

Authors:  R Ferro; A Adamska; R Lattanzio; I Mavrommati; C E Edling; S A Arifin; C A Fyffe; G Sala; L Sacchetto; G Chiorino; V De Laurenzi; M Piantelli; O J Sansom; T Maffucci; M Falasca
Journal:  Oncogene       Date:  2018-07-30       Impact factor: 9.867

7.  THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.

Authors:  Marc Richard Kolbe; Tim Hohmann; Urszula Hohmann; Chalid Ghadban; Ken Mackie; Christin Zöller; Julian Prell; Jörg Illert; Christian Strauss; Faramarz Dehghani
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

8.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

9.  A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

Authors:  Orgil Elbegdorj; Richard B Westkaemper; Yan Zhang
Journal:  J Mol Graph Model       Date:  2012-10-23       Impact factor: 2.518

10.  Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.

Authors:  Fabienne Briand-Mésange; Véronique Pons; Sophie Allart; Julien Masquelier; Gaëtan Chicanne; Nicolas Beton; Bernard Payrastre; Giulio G Muccioli; Jérôme Ausseil; Jean-Luc Davignon; Jean-Pierre Salles; Hugues Chap
Journal:  J Biol Chem       Date:  2020-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.